Hospital
Box Butte General Hospital
Box Butte General Hospital was paid $3.36M by Medicaid between Jan 2018 and Nov 2024, across 73 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.
33Billing provider infoBOX BUTTE GENERAL HOSPITAL
ALLIANCE, NE 69301
ALLIANCE, NE 69301
33aNPI1811929060assigned 07/07/2006
33bProvider typeCritical Access Hospital
28Total paid$3.36M
24GClaims52,654
24DCodes billed73
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Nebraska
Rank by total paid#3 of 53
Median peer was paid$593K
This provider vs. median5.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,726 | $587K | |
| 2019 | 10,520 | $732K | |
| 2020 | 9,195 | $633K | |
| 2021 | 10,547 | $655K | |
| 2022 | 8,535 | $479K | |
| 2023 | 4,250 | $244K | |
| 2024incomplete | 881 | $34K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 3,659 | 2,610 | $528K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 14% | 3,655 | 2,939 | $459K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 13% | 5,974 | 1,683 | $447K |
| 80050 | General health panel | 12% | 2,831 | 2,480 | $390K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.5% | 1,732 | 1,047 | $321K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.9% | 822 | 580 | $98K |
| G0378 | Hospital observation service, per hour | 2.4% | 129 | 109 | $82K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.4% | 808 | 698 | $82K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.4% | 944 | 899 | $81K |
| 71046 | Radiologic examination, chest; 2 views | 2.4% | 625 | 590 | $79K |
| 36415 | Collection of venous blood by venipuncture | 2.3% | 7,825 | 5,953 | $78K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.3% | 700 | 386 | $76K |
61 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.6% | 2,584 | $54K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 677 | $47K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.4% | 989 | $47K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 2,683 | $38K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 651 | $36K |
| 87088 | 1.1% | 942 | $36K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.0% | 422 | $35K |
| 80053 | Comprehensive metabolic panel | <1% | 2,251 | $26K |
| 83735 | <1% | 1,217 | $26K | |
| 81003 | <1% | 1,591 | $23K | |
| J3490 | Unclassified drugs | <1% | 2,508 | $23K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 277 | $21K |
| 81001 | <1% | 956 | $20K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 383 | $19K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 448 | $16K |
| 80061 | Lipid panel | <1% | 296 | $14K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 47 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 558 | $13K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 15 | $12K |
| 71045 | Radiologic examination, chest; single view | <1% | 138 | $11K |
| 87400 | <1% | 204 | $11K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 55 | $10K |
| 86140 | <1% | 354 | $9K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 138 | $9K |
| 87430 | <1% | 169 | $8K | |
| 87070 | <1% | 108 | $6K | |
| 11721 | <1% | 354 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 306 | $5K |
| 73610 | <1% | 25 | $3K | |
| 84484 | <1% | 76 | $3K | |
| 73630 | <1% | 26 | $3K | |
| 85610 | <1% | 232 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 58 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 104 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 16 | $3K |
| 87581 | <1% | 52 | $2K | |
| 83605 | <1% | 80 | $2K | |
| 87486 | <1% | 52 | $2K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 29 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 52 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 63 | $2K |
| 97161 | <1% | 26 | $2K | |
| 97162 | <1% | 13 | $1K | |
| 87186 | <1% | 55 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 46 | $1K |
| 82550 | <1% | 61 | $1K | |
| A9270 | Non-covered item or service | <1% | 20 | $1K |
| 80320 | <1% | 13 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 46 | $922.57 |
| 87420 | <1% | 12 | $854.09 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 197 | $850.99 |
| 83690 | <1% | 19 | $709.56 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 59 | $550.01 |
| 82962 | <1% | 47 | $533.84 | |
| A4222 | Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) | <1% | 27 | $517.96 |
| 87040 | <1% | 22 | $511.64 | |
| 82150 | <1% | 17 | $505.44 | |
| 81025 | <1% | 13 | $379.44 | |
| 85651 | <1% | 24 | $305.02 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 34 | $286.18 |
| 87077 | <1% | 13 | $200.30 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRIESS, DANIEL (CEO)
| Provider | Location | Paid |
|---|---|---|
| Box Butte General Hospital | Alliance, NE | $903K |
| Box Butte General Hospital | Alliance, NE | $12K |
| Box Butte General Hospital | Hemingford, NE | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.